Clinical Trials Directory

Trials / Completed

CompletedNCT01297907

Bronchial Hyperreactivity in Children With Crohn Disease

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
6 Years – 25 Years
Healthy volunteers
Accepted

Summary

Background: Latent pulmonary involvement is described in Crohn Disease(CD). Bronchial hyperreactivity measured by the Methacholine Challenge Test (MCT) has been evaluated in two studies involving mainly adults.Our aim was to determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for Crohn disease. Methods: Twenty-three children with Crohn disease completed a questionnaire, followed by spirometry, Methacholine Challenge Test (MCT) and determination of Fractional Exhaled NO (FENO). The control group included patients evaluated for functional cough who had negative Methacholine Challenge Test (MCT).

Conditions

Interventions

TypeNameDescription
OTHERMethacholine Challenge TestMethacholine challenge test to evaluate airway hyperreactivity
OTHERFractional Exhaled NO (FENO)Fractional Exhaled NO to evaluate eosinophilic inflammation
OTHERBlood TestBlood Tests (Eosinophil Count)
OTHERPCDAIClinical Evaluation for Pediatric Crohn's Disease Activity Index (PCDAI)

Timeline

Start date
2008-05-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2011-02-17
Last updated
2011-02-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01297907. Inclusion in this directory is not an endorsement.